Authors: Richard, N Salomon, H Oliveira, M Rando, R Mansour, T Gu, ZX Wainberg, MA

Citation: N. Richard et al., Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC, ANTIVIR CHE, 11(6), 2000, pp. 359-365

Authors: Murugesan, N Gu, ZX Stein, PD Spergel, S Mathur, A Leith, L Liu, ECK Zhang, RA Bird, E Waldron, T Marino, A Morrison, RA Webb, ML Moreland, S Barrish, JC

Citation: N. Murugesan et al., Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4 '-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ETAantagonists, J MED CHEM, 43(16), 2000, pp. 3111-3117

Authors: Gu, ZX Wainberg, MA Nguyen-Ba, P L'Heureux, L de Muys, JM Rando, RF

Citation: Zx. Gu et al., Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane, NUCLEOS NUC, 18(4-5), 1999, pp. 891-892

Authors: Gu, ZX Wainberg, MA Nguyen-Ba, N L'Heureux, L de Muys, JM Bowlin, TL Rando, RF

Citation: Zx. Gu et al., Mechanism of action and in vitro activity of 1 ',3 '-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants, ANTIM AG CH, 43(10), 1999, pp. 2376-2382

Authors: Murugesan, N Gu, ZX Stein, PD Bisaha, S Spergel, S Girotra, R Lee, VG Lloyd, J Misra, RN Schmidt, J Mathur, A Stratton, L Kelly, YF Bird, E Waldron, T Liu, ECK Zhang, RG Lee, H Serafino, R Abboa-Offei, B Mathers, P Giancarli, M Seymour, AA Webb, ML Moreland, S Barrish, JC Hunt, JT

Citation: N. Murugesan et al., Biphenylsulfonamide endothelin antagonists: Structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of theorally active endothelin antagonist 2 '-amino-N-(3,4-dimethyl-5-isoxazolyl)-4 '-(2-methylpropyl)[1,1 '-biphenyl]-2-sulfonamide (BMS-187308), J MED CHEM, 41(26), 1998, pp. 5198-5218